Is the CSL (ASX:CSL) share price good value today?

Is it time for the CSL share price to catch up with the market’s gains?
The post Is the CSL (ASX:CSL) share price good value today? appeared first on The Motley Fool Australia. –

The CSL Limited (ASX: CSL) share price hasn’t been getting much love from investors over the last 12 months.

During this time, the biotherapeutics giant’s shares are trading broadly flat. This compares to a 21% gain by the S&P/ASX 200 Index (ASX: XJO).

Is this a buying opportunity?

CSL has been operating for over a century. It was founded in 1916 with the aim of servicing the needs of a nation isolated by war. Today, the company is a global giant with a portfolio of therapies and vaccines saving countless lives across the world.

One of the keys to its success has been the company’s high level of investment in research and development. Every year CSL invests approximately 10% to 12% of its sales revenue back into its these activities. This has helped ensure that CSL is at the forefront of innovation and has a pipeline of potentially lucrative products.

Unfortunately, the company has been struggling with plasma collections during the pandemic. This is because lockdowns, social distancing, and government stimulus payments have all had negative impacts on donations.

Given that plasma is a core ingredient in many of its therapies, lower collections is bad news for CSL and is expected to drive costs higher. However, the good news here is that this headwind is only expected to be short-lived. In fact, recent data reveals that collections are already rebounding strongly and have been tipped to reach pre-COVID levels later this year.

In light of this, with the CSL share price still trading notably lower than its 52-week high, now could be an opportune time to make a long term investment.

Who rates the CSL share price as a buy?

One broker that thinks the CSL share price is in the buy zone is Citi.

It recently retained its buy rating and $310.00 price target. The broker believes that recent industry trends are looking favourable for the company.

Citi explained: “Over the last few weeks, most of CSL’s listed competitors have reported results. When we look at the data overall, it points to an improvement in the rate of plasma collection in April, which has been the main impediment to growth throughout the pandemic.”

“It also points to continued strong demand for the end-product, in particular IG. Overall this gives us confidence in our Buy call on CSL, although we are yet to see the earnings trough for the company which will occur in FY22 given the long lead times from plasma collection to sale.”

The post Is the CSL (ASX:CSL) share price good value today? appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!